At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
Michael Toth ā Executive Director - US Hematology - Promacta & Exjade/Jadenu at Novartis Oncology
Executive Bio
Michael Toth serves as the Executive Director - US Hematology - Promacta & Exjade/Jadenu of Novartis Oncology. Michael started at Novartis Oncology in June of 2018. Michael currently resides in the Greater New York City Area.
Executive Team Culture Ratings from Novartis Oncology Employees
TOP
30%
Novartis Oncology's Executive Team scores in the Top 30%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Novartis OncologyNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Novartis OncologyNovartis Oncology's Executive Team at a Glance
Based on 7 ratings, Novartis Oncology's employees are satisfied with their Executive Team and give them a āBā or 71/100.
Novartis Oncology's Executive Team ranks in the Top 35% of other companies in New York and Top 30% of other companies on Comparably that also have 10,000+ Employees.
×